| Year |
Title |
Altmetric |
| 2015
|
Effects of the dietary ω3:ω6 fatty acid ratio on body fat and inflammation in zebrafish (Danio rerio)
2015
|
|
| 2010
|
XIAP-mediated protection of H460 lung cancer cells against cisplatin
2010
|
|
| 2009
|
Molecules involve in the self-protection of neurons against glucose-oxygen-serum deprivation (GOSD)-induced cell damage.
Brain Research Bulletin.
79:169-176.
2009
|
|
| 2008
|
Ischemic brain cell-derived conditioned medium protects astrocytes against ischemia through GDNF/ERK/NF-kB signaling pathway.
Brain Research.
1239:24-35.
2008
|
|
| 2003
|
Cytokine and hormone profiles in mice subjected to handling combined with rectal temperature measurement stress and handling only stress.
Life Sciences.
72:1495-1508.
2003
|
|
| 2003
|
The phytoestrogen genistein suppresses cell-mediated immunity in mice.
Journal of Endocrinology.
176:267-274.
2003
|
|
| 2001
|
Effects of rotational stress of different duration on NK cell activity, proinflammatory cytokines, and POMC-derived peptides in mice.
Neuroimmunomodulation.
9:34-40.
2001
|
|
| 2000
|
Immunotherapy of a murine T cell lymphoma localized to the brain.
Journal of Neuro-Oncology.
47:1-10.
2000
|
|
| 2000
|
Nk Cell and Ctl Activities Can Be Raised Via Conditioning of the Cns with Unrelated Unconditioned Stimuli: Neuroimmunomodulation.
International Journal of Neuroscience.
103:79-89.
2000
|
|
| 1999
|
Psychoneuroendocrine immunology: Perception of stress can alter body temperature and natural killer cell activity.
International Journal of Neuroscience.
98:95-129.
1999
|
|
| 1997
|
Afferent signals to the cns appear not to condition the modulation of lnterleukin-1 receptors in the hippocampus.
Neuroimmunomodulation.
4:298-304.
1997
|
|
| 1997
|
Psychoneuroendocrine immunology: Site of recognition, learning and memory in the immune system and the brain.
International Journal of Neuroscience.
92:259-286.
1997
|
|
| 1996
|
Involvement of cytokine gene expression in the age-dependent decline of NK cell response.
Cellular Immunology.
173:221-229.
1996
|
|
| 1996
|
Activation of γ-opioid receptors are required for the conditioned enhancement of NK cell activity.
Brain Research.
737:263-268.
1996
|
|
| 1996
|
Conditioning of Body Temperature and Natural Killer Cell Activity with Arecoline, a Muscarinic Cholinergic Agonist.
Neuroimmunomodulation.
3:233-238.
1996
|
|
| 1996
|
Lipopolysaccharide and IL-1 α activate CNS pathways as measured by NK cell activity.
Physiology and Behavior.
59:499-504.
1996
|
|
| 1996
|
The use of conditioning to probe for CNS pathways that regulate fever and NK cell activity.
International Journal of Neuroscience.
84:229-245.
1996
|
|
| 1995
|
Expression of the conditioned NK cell activity is β-endorphin dependent.
Brain Research.
678:76-82.
1995
|
|
| 1995
|
Arecoline a muscarinic cholinergic agent conditions central pathways that modulate natural killer cell activity.
Journal of Neuroimmunology.
59:57-63.
1995
|
|
| 1995
|
Conditioning of the secondary cytotoxic T-lymphocyte response to YC8 tumor
1995
|
|
| 1994
|
Characterization of the synthesis and expression of the GTA-kinase from transformed and normal rodent cells
1994
|
|
| 1994
|
Effect of dexamethasone on conditioned enhancement of natural killer cell activity.
Neuroimmunomodulation.
1:370-376.
1994
|
|
| 1994
|
Efferent signal(s) responsible for the conditioned augmentation of natural killer cell activity..
Neuroimmunomodulation.
1:74-81.
1994
|
|
| 1994
|
Lidocaine interrupts the conditioned natural killer cell response by interfering with the conditioned stimulus.
Neuroimmunomodulation.
1:278-283.
1994
|
|
| 1994
|
Role of arcuate nucleus of the hypothalamus in the acquisition of association memory between the CS and US.
Journal of Neuroimmunology.
50:109-114.
1994
|
|
| 1994
|
Sodium carbonate prevents NK cell conditioning by interfering with the US signal.
International Journal of Neuroscience.
77:277-286.
1994
|
|
| 1994
|
Use of an allogeneic antigen to induce resistance and regression of an autologous tumor.
Journal of Immunotherapy.
15:202-211.
1994
|
|
| 1993
|
A multiple modality approach combining the effect of conditioning with adoptive chemoimmunotherapy.
International Journal of Neuroscience.
71:251-265.
1993
|
|
| 1993
|
Conditioning of the allogeneic cytotoxic lymphocyte response
1993
|
|
| 1993
|
Identification of specific pathways of communication between the CNS and NK cell system.
Life Sciences.
53:527-540.
1993
|
|
| 1993
|
The identity of the unconditioned stimulus to the central nervous system is interferon-β.
Journal of Neuroimmunology.
45:75-81.
1993
|
|
| 1992
|
The central effect of methionine-enkephalin on NK cell activity.
Brain Research.
578:142-148.
1992
|
|
| 1992
|
A Simple, Single, Trial-Learning Paradigm for Conditioned Increase in Natural Killer Cell Activity
1992
|
|
| 1992
|
Acquisition of enhanced natural killer cell activity under anesthesia.
Life Sciences.
50:2067-2074.
1992
|
|
| 1992
|
Indomethacin and sodium carbonate effects on conditioned fever and NK cell activity
1992
|
|
| 1992
|
The direction of the conditioned natural killer cell response can be re-directed with indomethacin and/or handling.
International Journal of Neuroscience.
67:229-239.
1992
|
|
| 1991
|
A behavioral augmentation of natural immunity: Odor specificity supports a pavlovian conditioning model.
International Journal of Neuroscience.
61:277-288.
1991
|
|
| 1991
|
Conditioning the elevation of body temperature, a host defensive reflex response.
Life Sciences.
49:93-99.
1991
|
|
| 1991
|
Effect of thymic hormone treatment on several immune functions of nude mice.
Mechanisms of Ageing and Development.
58:245-254.
1991
|
|
| 1991
|
In vivo enhancement of NK cell activity with met-enkephalin and glycyl-glutamine: Their possible role in the conditioned response.
International Journal of Neuroscience.
61:135-143.
1991
|
|
| 1991
|
Role of immune cells in the pavlovian conditioning of specific resistance to cancer.
International Journal of Neuroscience.
59:101-117.
1991
|
|
| 1991
|
Survey of Thymic Hormone Effects on Physical and Immunological Parameters in C57BL/6NNia Mice of Different Ages.
Annals of the New York Academy of Sciences.
621:239-255.
1991
|
|
| 1990
|
Conditioning: A New Approach to Immunotherapy.
Cancer Research.
50:4295-4299.
1990
|
|
| 1990
|
Characterization of 5b12.1, a monoclonal antibody specific for IL-6.
Growth Factors.
3:181-190.
1990
|
|
| 1990
|
Effect of reserpine on retention of the conditioned NK cell response
1990
|
|
| 1990
|
Host response to myeloma: Effect of syngeneic spleen cells on the growth and functionof MOPC 104e myeloma in vitro.
Cancer Investigation.
8:17-25.
1990
|
|
| 1990
|
Thymic peptides as anti-aging drugs: Effect of thymic hormones on immunity and life span.
International Journal of Neuroscience.
51:371-372.
1990
|
|
| 1989
|
Immunoregulation of murine plasmacytoma II. Target selectivity of anomalous killer cells and role of immune t cells for the induction.
Cancer Investigation.
7:27-38.
1989
|
|
| 1989
|
Immunoregulation of murine plasmacytoma i. Generation of anomalous killer cells in vitro by cocultivation with MOPC 104e.
Cancer Investigation.
7:17-26.
1989
|
|
| 1989
|
In vitro and in vivo growth control of transformed lymphoid cells expressing plasma membrane galactosyltransferase.
Oncogene.
4:1337-1344.
1989
|
|
| 1989
|
Naltrexone blocks the expression of the conditioned elevation of natural killer cell activity in BALB c mice.
Brain, Behavior, and Immunity.
3:247-262.
1989
|
|
| 1989
|
Regression of MOPC 104E plasmacytoma with monoclonal anti-idiotype antibodies.
Journal of biological response modifiers.
8:385-396.
1989
|
|
| 1988
|
Activation of natural killer cell function during interferon-α treatment of patients with condyloma acuminatum is predictive of clinical response.
Journal of Biological Regulators and Homeostatic Agents.
2:63-66.
1988
|
|
| 1988
|
Augmentation of Natural Immunity and Regulation of Tumor Growth by Conditioning.
Annals of the New York Academy of Sciences.
521:29-42.
1988
|
|
| 1988
|
Conditioned augmentation of natural killer cell activity. Independence from nociceptive effects and dependence on interferon-β.
Journal of Immunology.
140:661-665.
1988
|
|
| 1988
|
Host response to myeloma: I. Induction of cytotoxic and suppressor t cells by in vivo immunization with MOPC 104e plasmacytoma.
Cancer Investigation.
6:29-37.
1988
|
|
| 1987
|
Conditioned enhancement of natural killer cell activity, but not interferon, with camphor or saccharin‐Licl conditioned stimulus.
Journal of Neuroscience Research.
18:10-15.
1987
|
|
| 1987
|
Influence of Conditioned Natural Immunity on Tumor Growth.
Annals of the New York Academy of Sciences.
496:637-646.
1987
|
|
| 1987
|
Modulation of immune response. A possible role for murine salivary epidermal and nerve growth factors.
Journal of Periodontology.
58:498-500.
1987
|
|
| 1987
|
Regulation of Natural Immunity (NK Activity) by Conditioning.
Annals of the New York Academy of Sciences.
496:545-552.
1987
|
|
| 1986
|
In Vitro Effect of Monoclonal Anti-ldiotype Antibodies (Anti-M104E) on MOPC 104E Myeloma Cells.
Cancer Research.
46:1250-1254.
1986
|
|
| 1986
|
Induction of the plateau phase and rescue of MOPC 104e by nonspecific immunization.
Cancer Investigation.
4:525-533.
1986
|
|
| 1986
|
Spleen cell and thymocyte mitogen response in the presence of serum from castrate or intact male rats.
Contraceptive delivery systems.
2:248-255.
1986
|
|
| 1985
|
Neural and environmental influences on neoplasia and conditioning of NK activity.
Journal of Immunology.
135.
1985
|
|
| 1985
|
2,4-Diamino pteridine mustard: A new active-site-directed anticancer agent.
Proceedings of the American Association for Cancer Research.
VOL. 26.
1985
|
|
| 1985
|
Differential effects of monoclonal anti-idiotype antibodies on MOPC 104E myeloma.
The FASEB Journal.
44.
1985
|
|
| 1985
|
Effect of restraint stress and poly I:C on tumor growth and conditioning of NK activity (Pavlovian conditioning).
The FASEB Journal.
44.
1985
|
|
| 1985
|
Establishment of growth factor-dependent MOPC 104E cell line in vitro.
Cellular Immunology.
90:24-31.
1985
|
|
| 1985
|
Host regulation of MOPC 104e plasmacytoma after reduction of tumor burden by total body irradiation.
Cancer Investigation.
3:217-223.
1985
|
|
| 1985
|
Induction of plateau phase and rescue of MOPC 104E by non-specific immunization.
The FASEB Journal.
44.
1985
|
|
| 1985
|
Tumor burden, chemotherapy, and cell kill in osteosarcoma model
1985
|
|
| 1984
|
Inhibition of growth of MOPC 104E cells in immunosuppressed mice.
Journal of Immunology.
133:3424-3428.
1984
|
|
| 1984
|
NMR study of in vivo RIF-1 tumors. Analysis of perchloric acid extracts and identification of 1H, 31P and 13C resonances
1984
|
|
| 1984
|
Reduction of Tumor Burden in a Murine Osteosarcoma following Hyperthermia Combined with Cyclophosphamide.
Cancer Research.
44:1405-1408.
1984
|
|
| 1984
|
Loss of High-Energy Phosphate following Hyperthermia Demonstrated by in Vivo 31P-Nuclear Magnetic Resonance Spectroscopy.
Cancer Research.
44:633-638.
1984
|
|
| 1984
|
Effect of thymic hormone treatment in Nu/Nu mice.
The FASEB Journal.
43.
1984
|
|
| 1984
|
Effects of orchiectomy on spleen cell mitogen response and on the thymus of aged mice.
Experimental Aging Research.
10:189-191.
1984
|
|
| 1984
|
Growth factor dependent and growth factor independent MOPC 104E cell lines: Growth characteristics in vivo and in vitro.
The FASEB Journal.
43.
1984
|
|
| 1984
|
Natural suppressor factors in serum prevent generation of CTL in vivo.
The FASEB Journal.
43.
1984
|
|
| 1984
|
Regulation of mopc 104e by T cells and growth factors induced by C. Parvum stimulation.
International Journal of Cancer.
33:845-850.
1984
|
|
| 1983
|
MOPC 104E Plasmacytoma functional heterogeneity and maturational potential in culture.
Cancer Research.
43:953-958.
1983
|
|
| 1983
|
Tumor proliferation and chemotherapy in immunosuppressed mice.
Cancer Research.
43:1097-1100.
1983
|
|
| 1983
|
Alloreactivity. I. Effects of age and thymic hormone treatment on cell-mediated immunity in C57B1/6NNia mice.
Mechanisms of Ageing and Development.
22:309-319.
1983
|
|
| 1983
|
Investigation in the role of surgery, chemotherapy, and radiation in a murine osteosarcoma model
1983
|
|
| 1982
|
Mitogen response of peripheral blood and splenic lymphocytes and effect of 2-mercaptoethanol in tumor-bearing mice
1982
|
|
| 1982
|
Inhibitory Effect of L-Homoarginine on Murine Osteosarcoma cell proliferation.
Cancer Research.
42:1072-1077.
1982
|
|
| 1982
|
31P NMR spectroscopy of in vivo tumors.
Journal of Magnetic Resonance (1969).
49:271-286.
1982
|
|
| 1982
|
Antigenic determinants on lymphocytes from young and old C57BL/6 mice.
Experimental Gerontology.
17:375-381.
1982
|
|
| 1982
|
Effects of aging and thymic hormone treatment on cell-mediated cytotoxicity in C57BL/6 mice.
The FASEB Journal.
41:795.
1982
|
|
| 1982
|
Enhancement of maze learning in old C57BL/6 mice by dietary lecithin.
Neurobiology of Aging.
3:223-226.
1982
|
|
| 1982
|
Exploitable mechanisms in cancer therapy.
Proceedings of the American Association for Cancer Research.
Vol. 23.
1982
|
|
| 1982
|
Immunosuppressive effect of mouse serum lipoproteins. II. In vivo studies.
Journal of Immunology.
128:2107-2110.
1982
|
|
| 1981
|
Assessment of myeloma maintenance regimen of prednisone, adriamycin, imuran, and vincristine in a murine plasmacytoma model.
Cancer clinical trials.
4:135-141.
1981
|
|
| 1981
|
Effect of Immune Response to Sheep Red Blood Cells on Plasmacytoma MOPC 104 E.
Cancer Research.
41:2197-2199.
1981
|
|
| 1981
|
Immunosuppressive effect of mouse serum lipoproteins. I. In vitro studies.
Journal of Immunology.
126:1909-1913.
1981
|
|
| 1980
|
A murine plasmacytoma model for screening active drugs for human myeloma.
Cancer clinical trials.
3:395-402.
1980
|
|
| 1980
|
Characterization of an auto-rosette inhibitory fraction in mouse serum.
Journal of Immunology.
125:1298-1301.
1980
|
|
| 1980
|
Maintenance of MOPC 104E Myeloma in Plateau Phase.
Cancer Research.
40:2372-2376.
1980
|
|
| 1980
|
Osteosarcoma Associated Alkaline Phosphatase and In Vivo Growth and Development
1980
|
|
| 1980
|
Regulation of MOPC 104E cells in vivo following chemotherapy.
The FASEB Journal.
39:3115.
1980
|
|
| 1980
|
Surgical adjuvant chemotherapy of metastatic murine osteosarcoma.
International Journal of Cancer.
25:393-397.
1980
|
|
| 1979
|
A methodological approach to the prediction of anticancer drug effect in humans.
Cancer Research.
39:402-407.
1979
|
|
| 1979
|
Age related changes in auto-erythrocyte rosettes in the C57BL/6J and NZB/BINJ mice.
Mechanisms of Ageing and Development.
11:45-54.
1979
|
|
| 1979
|
Sequential appearance of auto-erythrocyte antibody immunoglobulin classes with age.
Journal of Gerontology.
34:177-182.
1979
|
|
| 1978
|
Age dependent reaction of mouse thymus cells with autologous and syngeneic erythrocytes.
Mechanisms of Ageing and Development.
8:329-339.
1978
|
|
| 1978
|
Development of an in vitro assay of antineoplastic drug efficacy with tumor models.
Proceedings of the American Association for Cancer Research.
Vol. 19.
1978
|
|
| 1978
|
Tumor immunology of experimental osteosarcoma..
Clinical Orthopaedics and Related Research.
133:246-260.
1978
|
|
| 1977
|
An Experimental Approach to Relate a Tumor-associated Enzyme Marker to Tumor Cell Numbers.
Cancer Research.
37:365-368.
1977
|
|
| 1977
|
Autoimmune disease antigens.
Journal of Oral Pathology and Medicine.
6:161-187.
1977
|
|
| 1977
|
Cis-Dichlorodiammineplatinum(II) Chemotherapy in Experimental Murine Myeloma MOPC 104E.
Cancer Research.
37:771-774.
1977
|
|
| 1977
|
Drug evaluation with experimental murine myeloma.
Proceedings of the American Association for Cancer Research.
Vol. 18.
1977
|
|
| 1977
|
In vitro pharmacokinetics of a tumor model, MOPC 104E murine tumor.
The FASEB Journal.
36.
1977
|
|
| 1976
|
IgM complex receptors on subpopulations of murine lymphocytes.
Journal of Immunology.
116:1199-1203.
1976
|
|
| 1976
|
Chemotherapy of multiple myeloma in experimental animals.
Proceedings of the American Association for Cancer Research.
Vol. 17.
1976
|
|
| 1976
|
Immunologic Suppression of DNA Synthesis in MOPC 104E Plasmacytoma Cells (39490)
1976
|
|
| 1976
|
Monitoring of Murine Osteosarcoma by Serial Alkaline Phosphatase Determinations
1976
|
|
| 1975
|
Evaluation of a Cooperative Group Human Myeloma Protocol Using the MOPC 104E Myeloma Model.
Cancer Research.
35:1309-1313.
1975
|
|
| 1975
|
Rat immunoglobulins in serum and secretions: Purification of rat IgM, IgA, and IgG and their quantitation in serum, colostrum, milk and saliva.
Immunochemistry.
12:817-823.
1975
|
|
| 1974
|
Complement levels in malnourished animals: measurement of complement in rat milk during the period of lactation.
Journal of the Reticuloendothelial Society.
16:213-219.
1974
|
|
| 1974
|
Complement levels in malnourished animals: quantification of serum complement in rat dams and their offspring.
Journal of the Reticuloendothelial Society.
16:204-212.
1974
|
|
| 1974
|
Acid-catalyzed hydrolysis of maltose and cellobiose 1-phenylflavazoles.
Carbohydrate Research.
35:255-258.
1974
|
|
| 1974
|
Chemotherapy and Rate of Kill of Tumor Cells in a Mouse Plasmacytoma.
Cancer Research.
34:1738-1742.
1974
|
|
| 1974
|
Measurement of antibody release from single cells. III. Rate of release of IgM from MOPC 104E plasmacytoma.
Journal of Immunology.
112:266-270.
1974
|
|
| 1974
|
Quantitation of antigens by immunoelectrophoresis.
Immunochemistry.
11:305-308.
1974
|
|
| 1974
|
Quantitation of total body tumor cells (MOPC 104E). I. Subcutaneous tumor model
1974
|
|
| 1974
|
Quantitation of total-body tumor cells (MOPC 104E). II. Ascites tumor model
1974
|
|
| 1973
|
A mathematical model for the quantitation of tumor and antibody forming cell populations within an animal's body.
Journal of Immunology.
111:1546-1553.
1973
|
|
| 1973
|
Studies of MOPC 104E plasmacytoma cells forming rosettes with autologous and syngeneic erythrocytes.
Journal of Immunology.
111:893-899.
1973
|
|
| 1973
|
A Modified Immunofluorescence Technique for Detection of Surface Ig
1973
|
|
| 1973
|
Methodology a study of the single radial hemolysis in gel system-III. Quantitation of complement.
Immunochemistry.
10:645-649.
1973
|
|
| 1973
|
Use of fluorescein conjugated dextran for the detection of MOPC 104E tumor cells.
Immunochemistry.
10:51-53.
1973
|
|
| 1972
|
Use of dextran-conjugated SRBC for the detection of MOPC 104E tumor cells..
Journal of Immunology.
109:810-815.
1972
|
|
| 1972
|
Use of dextran conjugated columns for the isolation of large quantities of MOPC 104E IgM.
Immunochemistry.
9.
1972
|
|
